Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Stintzing

Showing results (111-120 of 206) with videos related to

Pageof 21
Sort By:
Cancers|October 17, 2020
Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer PatientsNico B Volz, Diana L Hanna, Sebastian Stintzing, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
NeoRAS wild-type in metastatic colorectal cancer: Myth or truth?-Case series and review of the literatureHiroki Osumi, Loredana Vecchione, Ulrich Keilholz, et al.
Cancer Treatment Reviews|May 14, 2021
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancerJean Bourhis, Alexander Stein, Jan Paul de Boer, et al.
Frontiers in Oncology|June 1, 2022
Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer CentersLaura E Fischer, Sebastian Stintzing, Volker Heinemann, et al.
Molecular Cancer Therapeutics|October 31, 2013
Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapyYan Ning, Armin Gerger, Wu Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancerHiroyuki Arai, Joshua Millstein, Fotios Loupakis, et al.
Eclinicalmedicine|February 23, 2023
Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trialsJingyuan Wang, Joshua Millstein, Yan Yang, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2023
Tumour mutational burden and survival with molecularly matched therapyTill de Bortoli, Manuela Benary, Peter Horak, et al.
Zeitschrift Fur Gastroenterologie|June 17, 2020
[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations]Ulrike Attenberger, Claus Rödel, Michael Ghadimi, et al.
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Pageof 21

Showing results (111-120 of 206) with videos related to

Sort By:
Pageof 21
Cancers|October 17, 2020
Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer PatientsNico B Volz, Diana L Hanna, Sebastian Stintzing, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
NeoRAS wild-type in metastatic colorectal cancer: Myth or truth?-Case series and review of the literatureHiroki Osumi, Loredana Vecchione, Ulrich Keilholz, et al.
Cancer Treatment Reviews|May 14, 2021
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancerJean Bourhis, Alexander Stein, Jan Paul de Boer, et al.
Frontiers in Oncology|June 1, 2022
Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer CentersLaura E Fischer, Sebastian Stintzing, Volker Heinemann, et al.
Molecular Cancer Therapeutics|October 31, 2013
Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapyYan Ning, Armin Gerger, Wu Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancerHiroyuki Arai, Joshua Millstein, Fotios Loupakis, et al.
Eclinicalmedicine|February 23, 2023
Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trialsJingyuan Wang, Joshua Millstein, Yan Yang, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2023
Tumour mutational burden and survival with molecularly matched therapyTill de Bortoli, Manuela Benary, Peter Horak, et al.
Zeitschrift Fur Gastroenterologie|June 17, 2020
[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations]Ulrike Attenberger, Claus Rödel, Michael Ghadimi, et al.
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Pageof 21